All About Oncology --- Plunes HealthCare
•
0 likes•5 views
Oncologists work on identifying and minimizing risk factors associated with cancer. This can involve lifestyle changes, vaccinations (such as the HPV vaccine to prevent cervical cancer), and genetic counselling for individuals with a family history of certain cancers.
Report
Share
Report
Share
Download to read offline
Recommended
Oncologie medicala
Oncologia medicală este specialitatea care se ocupă cu studiul apariţiei şi dezvoltării neoplaziilor maligne, urmărind depistarea, diagnosticul, tratamentul cât şi evoluţia posterapeutică a pacienţilor.
Cancer Clinical Trials_ USA Scenario and Study Designs.pdf
Clinical trials in oncology are vital for the advancement of cancer treatments and
care. The US is at the forefront of these clinical trials, with many different study
designs being used to assess the efficacy and safety of new treatments. This article
will explore the current state of oncology clinical trial services in the US, as well as
discuss different types of study designs that are commonly used. It will provide
insight into how these trials are conducted, what data is collected, and how this
information can be used to improve patient care.
The United States Food and Drug Administration (FDA) has released
several guidance documents over the years through the Oncology Center
of Excellence to support the development of oncologic treatments and
diagnoses. Furthermore, information on the clinical trials for the treatment
of different types of cancer or specific interventions can be found on the
National Cancer Institute (NCI) website and Clinical Trials. Currently,
ClinicalTrials.gov, a website maintained by the National Library of
Medicine (NLM) and the National Institutes of Health (NIH) contains
listings of publicly and privately sponsored trials and includes information
on 91,937 studies related to cancer indicating the high volume of
research being conducted in this field.According to the World Health Organization (WHO), cancer is the leading
cause of death worldwide, with a death rate of one in six in 2020 (1).
Aside from the high mortality rate and morbidity associated with cancer, it
also negatively impacts the quality of life and poses a significant financial
burden on patients and payers making it imperative to develop effective
treatments for the disease. According to Global Cancer Observatory
(GLOBACAN), the United States accounted for 13.3% of all estimated
new cases of cancer in 2020 (2). In 2020, the single leading type of
cancer in the United States was breast cancer (11.1%) followed by lung
cancer (10%), prostrate (9,2%), colorectum (6.8%), and melanoma of the
skin (4.2%). Despite the significant prevalence of cancer and numerous
clinical trials conducted for oncology treatments, data have shown an
almost 95% attrition rate for anticancer drugs from Phase I trials until
marketing authorization. Various factors such as inaccurate preclinical
models, lack of suitable biomarkers in clinical trials, and a disconnect
between industry, academia, and regulators are responsible for the high
attrition rate (3). Therefore, it is vital to develop suitable study designs
and protocols for candidate molecules such that they obtain regulatory
approval and can be marketed. In addition to these challenges, the
development of anti-cancer agents comes at a monumental cost of an
estimated $2.8 billion. Several factors such as the choice of relevant
endpoints, the choice of appropriate biomarkers that are guided by tumor
biology, and careful patient selection are expected to improve the overall
fate of oncologic agents in the clinical trial phase
Understanding the Branches of Oncology.pptx
Oncology is the medical discipline dedicated to the study, diagnosis, and treatment of cancer.
Advancements and Challenges: Cancer treatment in China.pptx
China's headway in oncology treatment manifests across various dimensions. Initially, the nation has observed substantial investments in medical exploration and infrastructure, nurturing partnerships between academia, industry, and healthcare entities. Breakthroughs in cancer genomics, immunotherapy, and precision medicine have propelled treatment efficiency and patient results.
Precision medicine, notably, has emerged as a promising frontier in cancer care. By harnessing genomic scrutiny and molecular profiling, clinicians can customize therapies for individual patients, optimizing effectiveness while minimizing adverse repercussions. China's endeavors in genomic sequencing and data analytics have hastened the adoption of precision oncology, offering fresh prospects to patients with previously untreatable malignancies.
Furthermore, China has emerged as a pivotal participant in global clinical trials, enticing multinational pharmaceutical corporations to conduct research and devise innovative therapies within its boundaries. This surge of investment not only broadens treatment alternatives for Chinese patients but also enriches the nation's scientific competencies and healthcare infrastructure.
Concurrently with contemporary medical strides, traditional Chinese medicine (TCM) continues to wield a substantial influence in cancer therapy. Herbal remedies, acupuncture, and qigong therapy are amalgamated into numerous cancer care regimens, striving to alleviate symptoms, boost quality of life, and complement conventional treatments.
While some traditional practices lack robust scientific authentication, others have exhibited promise in enhancing patient outcomes and alleviating treatment-linked side effects. China's healthcare system embraces this holistic approach, providing patients with a diverse array of treatment modalities tailored to their distinct needs and inclinations.
Despite remarkable progress, China's oncology landscape confronts several hurdles. Access to top-tier care remains irregular, with discrepancies prevailing between urban and rural regions, as well as among socioeconomic strata. Additionally, the nation grapples with escalating cancer prevalence attributed to factors such as an aging demographic, environmental contamination, and lifestyle alterations.
Moreover, the affordability of cancer therapies poses a substantial impediment to numerous patients, particularly for innovative therapies and targeted medications. While the Chinese government has enacted policies to enhance access to indispensable medicines and healthcare amenities, addressing the financial strain of cancer care demands sustained endeavors and innovative resolutions.
In summation, China's odyssey in combating cancer epitomizes a multifaceted approach that embraces both contemporary medical strides and traditional remedial practices.
Recommended
Oncologie medicala
Oncologia medicală este specialitatea care se ocupă cu studiul apariţiei şi dezvoltării neoplaziilor maligne, urmărind depistarea, diagnosticul, tratamentul cât şi evoluţia posterapeutică a pacienţilor.
Cancer Clinical Trials_ USA Scenario and Study Designs.pdf
Clinical trials in oncology are vital for the advancement of cancer treatments and
care. The US is at the forefront of these clinical trials, with many different study
designs being used to assess the efficacy and safety of new treatments. This article
will explore the current state of oncology clinical trial services in the US, as well as
discuss different types of study designs that are commonly used. It will provide
insight into how these trials are conducted, what data is collected, and how this
information can be used to improve patient care.
The United States Food and Drug Administration (FDA) has released
several guidance documents over the years through the Oncology Center
of Excellence to support the development of oncologic treatments and
diagnoses. Furthermore, information on the clinical trials for the treatment
of different types of cancer or specific interventions can be found on the
National Cancer Institute (NCI) website and Clinical Trials. Currently,
ClinicalTrials.gov, a website maintained by the National Library of
Medicine (NLM) and the National Institutes of Health (NIH) contains
listings of publicly and privately sponsored trials and includes information
on 91,937 studies related to cancer indicating the high volume of
research being conducted in this field.According to the World Health Organization (WHO), cancer is the leading
cause of death worldwide, with a death rate of one in six in 2020 (1).
Aside from the high mortality rate and morbidity associated with cancer, it
also negatively impacts the quality of life and poses a significant financial
burden on patients and payers making it imperative to develop effective
treatments for the disease. According to Global Cancer Observatory
(GLOBACAN), the United States accounted for 13.3% of all estimated
new cases of cancer in 2020 (2). In 2020, the single leading type of
cancer in the United States was breast cancer (11.1%) followed by lung
cancer (10%), prostrate (9,2%), colorectum (6.8%), and melanoma of the
skin (4.2%). Despite the significant prevalence of cancer and numerous
clinical trials conducted for oncology treatments, data have shown an
almost 95% attrition rate for anticancer drugs from Phase I trials until
marketing authorization. Various factors such as inaccurate preclinical
models, lack of suitable biomarkers in clinical trials, and a disconnect
between industry, academia, and regulators are responsible for the high
attrition rate (3). Therefore, it is vital to develop suitable study designs
and protocols for candidate molecules such that they obtain regulatory
approval and can be marketed. In addition to these challenges, the
development of anti-cancer agents comes at a monumental cost of an
estimated $2.8 billion. Several factors such as the choice of relevant
endpoints, the choice of appropriate biomarkers that are guided by tumor
biology, and careful patient selection are expected to improve the overall
fate of oncologic agents in the clinical trial phase
Understanding the Branches of Oncology.pptx
Oncology is the medical discipline dedicated to the study, diagnosis, and treatment of cancer.
Advancements and Challenges: Cancer treatment in China.pptx
China's headway in oncology treatment manifests across various dimensions. Initially, the nation has observed substantial investments in medical exploration and infrastructure, nurturing partnerships between academia, industry, and healthcare entities. Breakthroughs in cancer genomics, immunotherapy, and precision medicine have propelled treatment efficiency and patient results.
Precision medicine, notably, has emerged as a promising frontier in cancer care. By harnessing genomic scrutiny and molecular profiling, clinicians can customize therapies for individual patients, optimizing effectiveness while minimizing adverse repercussions. China's endeavors in genomic sequencing and data analytics have hastened the adoption of precision oncology, offering fresh prospects to patients with previously untreatable malignancies.
Furthermore, China has emerged as a pivotal participant in global clinical trials, enticing multinational pharmaceutical corporations to conduct research and devise innovative therapies within its boundaries. This surge of investment not only broadens treatment alternatives for Chinese patients but also enriches the nation's scientific competencies and healthcare infrastructure.
Concurrently with contemporary medical strides, traditional Chinese medicine (TCM) continues to wield a substantial influence in cancer therapy. Herbal remedies, acupuncture, and qigong therapy are amalgamated into numerous cancer care regimens, striving to alleviate symptoms, boost quality of life, and complement conventional treatments.
While some traditional practices lack robust scientific authentication, others have exhibited promise in enhancing patient outcomes and alleviating treatment-linked side effects. China's healthcare system embraces this holistic approach, providing patients with a diverse array of treatment modalities tailored to their distinct needs and inclinations.
Despite remarkable progress, China's oncology landscape confronts several hurdles. Access to top-tier care remains irregular, with discrepancies prevailing between urban and rural regions, as well as among socioeconomic strata. Additionally, the nation grapples with escalating cancer prevalence attributed to factors such as an aging demographic, environmental contamination, and lifestyle alterations.
Moreover, the affordability of cancer therapies poses a substantial impediment to numerous patients, particularly for innovative therapies and targeted medications. While the Chinese government has enacted policies to enhance access to indispensable medicines and healthcare amenities, addressing the financial strain of cancer care demands sustained endeavors and innovative resolutions.
In summation, China's odyssey in combating cancer epitomizes a multifaceted approach that embraces both contemporary medical strides and traditional remedial practices.
Oncology and Ocosurgery
Oncology is that department of medicine that deals with tumors. A medical professional who practices oncology is an oncologist.This includes the detection of any cancer in person , therapies, post care of cancer patients after treatments in the superspeciality hospitals
Principles of oncology
This PPT is based on the topic in Bailey & Love chapter and mostly useful for Final yr. M.B.B.S.students.
ROJoson PEP Talk: Cancer Management - FundaGen - Part 2
ROJoson PEP Talk: Cancer Management - FundaGen - Part 2
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©
CHAPTER 175
Overview of Cancer and Treatment
Jennifer Duff, MD
Merry Jennifer Markham, MD
Key Clinical Questions
What types of biopsies can aid in the diagnostic workup of cancer?
How is the cancer stage determined?
What are the goals of therapy in the neoadjuvant, adjuvant, and palliative setting?
What are the different types of systemic therapies commonly used in the
treatment of cancer?
What are the approaches to treating chemotherapy-related nausea, vomiting and
mucositis?
When are modified blood products recommended for cancer patients and what
are the transfusion thresholds for anemia and thrombocytopenia?
EPIDEMIOLOGY
Cancer is a group of diseases characterized by uncontrolled proliferation of abnormal
cells that invade surrounding tissue and carry the potential to metastasize. Environmental
1578185 - McGraw-Hill Professional ©
and lifestyle risk factors and genetic susceptibility all contribute to an individual’s risk of
developing cancer. In 2015, more than 1.6 million Americans will be diagnosed with
cancer, and approximately 600,000 cancer-related deaths will occur. The most common
cancers afflicting men and women are prostate and breast, respectively, followed by lung
and colorectal. Overall, lung cancer is the leading cause of cancer-related mortality,
followed by colorectal cancer. The incidence of lung and colon cancer in men is steadily
declining, perhaps reflecting decreased tobacco use and emphasis on colorectal cancer
screenings. Lung cancer incidence in women is finally starting to decrease after rising over
the last few decades, reflecting the delayed uptake in smoking (and later, smoking
cessation) by women compared to men.
DIAGNOSIS AND STAGING
Biopsy of a primary and/or metastatic site of a presumed malignancy is necessary to
provide histologic confirmation of a cancer diagnosis. Involving a hematologist-oncologist
early in the workup of a newly diagnosed cancer patient can be helpful in guiding the
appropriate testing, biopsy sites, or biopsy techniques. For example, different biopsy
techniques—including fine needle aspiration (FNA), core needle biopsy, excisional biopsy,
or laparotomy—may be utilized depending on the type of cancer suspected. An FNA alone
is inadequate in the diagnosis of lymphomas as the morphology of the nodal tissue is
crucial in determining lymphoma subtype. Core needle biopsies and excisional or
incisional biopsies provide a larger volume of tissue for pathologic evaluation of
morphology and for molecular or genetic analysis. When a hematologic malignancy, such
as lymphoma, is suspected, sending a fresh, not fixed, specimen for comprehensive
immunophenotyping using flow cytometry is important in yielding the correct diagnosis.
Finally, in addition to confirming a cancer diagnosis, the biopsied tissue specimen may
guide therapeutic decisions. For example, molecular biomarkers, such as HER2Neu for
breast cancer and KRAS/NRAS for colon cancer ...
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©
CHAPTER 175
Overview of Cancer and Treatment
Jennifer Duff, MD
Merry Jennifer Markham, MD
Key Clinical Questions
What types of biopsies can aid in the diagnostic workup of cancer?
How is the cancer stage determined?
What are the goals of therapy in the neoadjuvant, adjuvant, and palliative setting?
What are the different types of systemic therapies commonly used in the
treatment of cancer?
What are the approaches to treating chemotherapy-related nausea, vomiting and
mucositis?
When are modified blood products recommended for cancer patients and what
are the transfusion thresholds for anemia and thrombocytopenia?
EPIDEMIOLOGY
Cancer is a group of diseases characterized by uncontrolled proliferation of abnormal
cells that invade surrounding tissue and carry the potential to metastasize. Environmental
1578185 - McGraw-Hill Professional ©
and lifestyle risk factors and genetic susceptibility all contribute to an individual’s risk of
developing cancer. In 2015, more than 1.6 million Americans will be diagnosed with
cancer, and approximately 600,000 cancer-related deaths will occur. The most common
cancers afflicting men and women are prostate and breast, respectively, followed by lung
and colorectal. Overall, lung cancer is the leading cause of cancer-related mortality,
followed by colorectal cancer. The incidence of lung and colon cancer in men is steadily
declining, perhaps reflecting decreased tobacco use and emphasis on colorectal cancer
screenings. Lung cancer incidence in women is finally starting to decrease after rising over
the last few decades, reflecting the delayed uptake in smoking (and later, smoking
cessation) by women compared to men.
DIAGNOSIS AND STAGING
Biopsy of a primary and/or metastatic site of a presumed malignancy is necessary to
provide histologic confirmation of a cancer diagnosis. Involving a hematologist-oncologist
early in the workup of a newly diagnosed cancer patient can be helpful in guiding the
appropriate testing, biopsy sites, or biopsy techniques. For example, different biopsy
techniques—including fine needle aspiration (FNA), core needle biopsy, excisional biopsy,
or laparotomy—may be utilized depending on the type of cancer suspected. An FNA alone
is inadequate in the diagnosis of lymphomas as the morphology of the nodal tissue is
crucial in determining lymphoma subtype. Core needle biopsies and excisional or
incisional biopsies provide a larger volume of tissue for pathologic evaluation of
morphology and for molecular or genetic analysis. When a hematologic malignancy, such
as lymphoma, is suspected, sending a fresh, not fixed, specimen for comprehensive
immunophenotyping using flow cytometry is important in yielding the correct diagnosis.
Finally, in addition to confirming a cancer diagnosis, the biopsied tissue specimen may
guide therapeutic decisions. For example, molecular biomarkers, such as HER2Neu for
breast cancer and KRAS/NRAS for colon cancer ...
Modalities of treatment for cancer
There are many types of cancer treatment. The types of treatment that patient receive will depend on the type of cancer, stage of cancer and how advanced it is.
Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy.
Introduction to Cancer: Focus on Solid Tumors Course, organized by Healthcare...
Delegates attending this course will benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs will be reviewed, including immunotherapies. The range of side-effects of cancer treatments will be studied in detail. Quality-of-life issues in terms of overall assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumor types: breast, lung, upper gastrointestinal (GI), colorectal, melanoma, ovarian and prostate cancer.
Personalized medicine in pediatric cancer
The maturation of genomic technologies has enabled new
discoveries in disease pathogenesis as well as new approaches to patient care.
In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment.
Several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine.
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the...
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the...PVI, PeerView Institute for Medical Education
Chair and Presenter, Sumanta Kumar Pal, MD, FASCO, Pedro C. Barata, MD, MSc, Toni K. Choueiri, MD, and Cristina Suarez, MD, PhD, prepared useful Practice Aids pertaining to renal cell carcinoma for this CME/MOC/NCPD/AAPA activity titled “Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the Disease Spectrum.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3yGnLnD. CME/MOC/NCPD/AAPA credit will be available until July 2, 2024.Breat cancer
Breast cancer is a malignancy originating from breast tissue. This chapter
distinguishes between early stages, which are potentially curable, and
metastatic breast cancer (MBC), which is usually incurable.
Literature on Cancer and anti-cancer drugs.pptx
Short, basic information about cancer and anti-cancer drugs.
At What Stage Does Cancer Become Painful?
This presentation delves into the timing and factors influencing the emergence of pain in cancer patients. It examines how cancer progression, location, and individual differences contribute to the onset of pain, emphasizing the need for tailored pain management strategies.
Can Water Pollution Increase Cancer Risk?
Explore the complicated connection between water pollution and cancer risk, understanding the effects of pollutants, epidemiological data, legal limitations, and Plunes Healthcare's cancer support services.
More Related Content
Similar to All About Oncology --- Plunes HealthCare
Oncology and Ocosurgery
Oncology is that department of medicine that deals with tumors. A medical professional who practices oncology is an oncologist.This includes the detection of any cancer in person , therapies, post care of cancer patients after treatments in the superspeciality hospitals
Principles of oncology
This PPT is based on the topic in Bailey & Love chapter and mostly useful for Final yr. M.B.B.S.students.
ROJoson PEP Talk: Cancer Management - FundaGen - Part 2
ROJoson PEP Talk: Cancer Management - FundaGen - Part 2
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©
CHAPTER 175
Overview of Cancer and Treatment
Jennifer Duff, MD
Merry Jennifer Markham, MD
Key Clinical Questions
What types of biopsies can aid in the diagnostic workup of cancer?
How is the cancer stage determined?
What are the goals of therapy in the neoadjuvant, adjuvant, and palliative setting?
What are the different types of systemic therapies commonly used in the
treatment of cancer?
What are the approaches to treating chemotherapy-related nausea, vomiting and
mucositis?
When are modified blood products recommended for cancer patients and what
are the transfusion thresholds for anemia and thrombocytopenia?
EPIDEMIOLOGY
Cancer is a group of diseases characterized by uncontrolled proliferation of abnormal
cells that invade surrounding tissue and carry the potential to metastasize. Environmental
1578185 - McGraw-Hill Professional ©
and lifestyle risk factors and genetic susceptibility all contribute to an individual’s risk of
developing cancer. In 2015, more than 1.6 million Americans will be diagnosed with
cancer, and approximately 600,000 cancer-related deaths will occur. The most common
cancers afflicting men and women are prostate and breast, respectively, followed by lung
and colorectal. Overall, lung cancer is the leading cause of cancer-related mortality,
followed by colorectal cancer. The incidence of lung and colon cancer in men is steadily
declining, perhaps reflecting decreased tobacco use and emphasis on colorectal cancer
screenings. Lung cancer incidence in women is finally starting to decrease after rising over
the last few decades, reflecting the delayed uptake in smoking (and later, smoking
cessation) by women compared to men.
DIAGNOSIS AND STAGING
Biopsy of a primary and/or metastatic site of a presumed malignancy is necessary to
provide histologic confirmation of a cancer diagnosis. Involving a hematologist-oncologist
early in the workup of a newly diagnosed cancer patient can be helpful in guiding the
appropriate testing, biopsy sites, or biopsy techniques. For example, different biopsy
techniques—including fine needle aspiration (FNA), core needle biopsy, excisional biopsy,
or laparotomy—may be utilized depending on the type of cancer suspected. An FNA alone
is inadequate in the diagnosis of lymphomas as the morphology of the nodal tissue is
crucial in determining lymphoma subtype. Core needle biopsies and excisional or
incisional biopsies provide a larger volume of tissue for pathologic evaluation of
morphology and for molecular or genetic analysis. When a hematologic malignancy, such
as lymphoma, is suspected, sending a fresh, not fixed, specimen for comprehensive
immunophenotyping using flow cytometry is important in yielding the correct diagnosis.
Finally, in addition to confirming a cancer diagnosis, the biopsied tissue specimen may
guide therapeutic decisions. For example, molecular biomarkers, such as HER2Neu for
breast cancer and KRAS/NRAS for colon cancer ...
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©
CHAPTER 175
Overview of Cancer and Treatment
Jennifer Duff, MD
Merry Jennifer Markham, MD
Key Clinical Questions
What types of biopsies can aid in the diagnostic workup of cancer?
How is the cancer stage determined?
What are the goals of therapy in the neoadjuvant, adjuvant, and palliative setting?
What are the different types of systemic therapies commonly used in the
treatment of cancer?
What are the approaches to treating chemotherapy-related nausea, vomiting and
mucositis?
When are modified blood products recommended for cancer patients and what
are the transfusion thresholds for anemia and thrombocytopenia?
EPIDEMIOLOGY
Cancer is a group of diseases characterized by uncontrolled proliferation of abnormal
cells that invade surrounding tissue and carry the potential to metastasize. Environmental
1578185 - McGraw-Hill Professional ©
and lifestyle risk factors and genetic susceptibility all contribute to an individual’s risk of
developing cancer. In 2015, more than 1.6 million Americans will be diagnosed with
cancer, and approximately 600,000 cancer-related deaths will occur. The most common
cancers afflicting men and women are prostate and breast, respectively, followed by lung
and colorectal. Overall, lung cancer is the leading cause of cancer-related mortality,
followed by colorectal cancer. The incidence of lung and colon cancer in men is steadily
declining, perhaps reflecting decreased tobacco use and emphasis on colorectal cancer
screenings. Lung cancer incidence in women is finally starting to decrease after rising over
the last few decades, reflecting the delayed uptake in smoking (and later, smoking
cessation) by women compared to men.
DIAGNOSIS AND STAGING
Biopsy of a primary and/or metastatic site of a presumed malignancy is necessary to
provide histologic confirmation of a cancer diagnosis. Involving a hematologist-oncologist
early in the workup of a newly diagnosed cancer patient can be helpful in guiding the
appropriate testing, biopsy sites, or biopsy techniques. For example, different biopsy
techniques—including fine needle aspiration (FNA), core needle biopsy, excisional biopsy,
or laparotomy—may be utilized depending on the type of cancer suspected. An FNA alone
is inadequate in the diagnosis of lymphomas as the morphology of the nodal tissue is
crucial in determining lymphoma subtype. Core needle biopsies and excisional or
incisional biopsies provide a larger volume of tissue for pathologic evaluation of
morphology and for molecular or genetic analysis. When a hematologic malignancy, such
as lymphoma, is suspected, sending a fresh, not fixed, specimen for comprehensive
immunophenotyping using flow cytometry is important in yielding the correct diagnosis.
Finally, in addition to confirming a cancer diagnosis, the biopsied tissue specimen may
guide therapeutic decisions. For example, molecular biomarkers, such as HER2Neu for
breast cancer and KRAS/NRAS for colon cancer ...
Modalities of treatment for cancer
There are many types of cancer treatment. The types of treatment that patient receive will depend on the type of cancer, stage of cancer and how advanced it is.
Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy.
Introduction to Cancer: Focus on Solid Tumors Course, organized by Healthcare...
Delegates attending this course will benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs will be reviewed, including immunotherapies. The range of side-effects of cancer treatments will be studied in detail. Quality-of-life issues in terms of overall assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumor types: breast, lung, upper gastrointestinal (GI), colorectal, melanoma, ovarian and prostate cancer.
Personalized medicine in pediatric cancer
The maturation of genomic technologies has enabled new
discoveries in disease pathogenesis as well as new approaches to patient care.
In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment.
Several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine.
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the...
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the...PVI, PeerView Institute for Medical Education
Chair and Presenter, Sumanta Kumar Pal, MD, FASCO, Pedro C. Barata, MD, MSc, Toni K. Choueiri, MD, and Cristina Suarez, MD, PhD, prepared useful Practice Aids pertaining to renal cell carcinoma for this CME/MOC/NCPD/AAPA activity titled “Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the Disease Spectrum.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3yGnLnD. CME/MOC/NCPD/AAPA credit will be available until July 2, 2024.Breat cancer
Breast cancer is a malignancy originating from breast tissue. This chapter
distinguishes between early stages, which are potentially curable, and
metastatic breast cancer (MBC), which is usually incurable.
Literature on Cancer and anti-cancer drugs.pptx
Short, basic information about cancer and anti-cancer drugs.
Similar to All About Oncology --- Plunes HealthCare (20)
ROJoson PEP Talk: Cancer Management - FundaGen - Part 2
ROJoson PEP Talk: Cancer Management - FundaGen - Part 2
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
1578185 - McGraw-Hill Professional ©CHAPTER 175Overview
Introduction to Cancer: Focus on Solid Tumors Course, organized by Healthcare...
Introduction to Cancer: Focus on Solid Tumors Course, organized by Healthcare...
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the...
Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the...
Cancer and anti-cancer drugs and drug molecules.pptx
Cancer and anti-cancer drugs and drug molecules.pptx
More from PlunesHealthCare
At What Stage Does Cancer Become Painful?
This presentation delves into the timing and factors influencing the emergence of pain in cancer patients. It examines how cancer progression, location, and individual differences contribute to the onset of pain, emphasizing the need for tailored pain management strategies.
Can Water Pollution Increase Cancer Risk?
Explore the complicated connection between water pollution and cancer risk, understanding the effects of pollutants, epidemiological data, legal limitations, and Plunes Healthcare's cancer support services.
6 Unique Symptoms of Colon Cancer in Women
Discover expert guidance and comprehensive support for colon cancer at Plunes Healthcare. Personalized treatment plans, leading specialists, and advanced diagnostics ensure optimal care every step of the way.
Empowering Action: Fighting Oral Cancer Together
Empower action against oral cancer with our infographic! Discover prevention tips, early detection methods, treatment options, and ways to support those affected. Let's fight oral cancer together!
Causes Of Throat Cancer - Plunes Healthcare
Enhance your knowledge of throat cancer alongside Plunes Healthcare. Explore the causes behind throat cancer and understand the pivotal role Plunes Healthcare plays in combatting it.
Liver Cancer Understanding, Risks, and Care
Explore the essentials of liver cancer, covering its types, risk factors, symptoms, treatment options, prevention strategies, and how Plunes Healthcare supports patients through their liver cancer journey.
All About Bladder Cancer - Plunes HealthCare
Bladder cancer is a complex disease with various symptoms, causes, and treatment options. Early detection and prompt treatment are crucial for improving outcomes and quality of life for individuals diagnosed with this condition.
Colon Cancer PPT
Colon cancer is a significant public health concern, but with early detection and advances in treatment, many cases can be effectively managed or cured. Regular screenings and a healthy lifestyle are vital in preventing and addressing colon cancer.
More from PlunesHealthCare (8)
Recently uploaded
The positive impact of SGRT – The Berkshire Cancer Centre experience
SGRT Europe 2023
Victoria Hammond-Turner
Technical and Development Lead Therapeutic Radiographer
Royal Berkshire NHS Foundation Trust, UK
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
原版定制【微信:41543339】【纽约大学毕业证(NYU毕业证)】【微信:41543339】成绩单、外壳、offer、留信学历认证（永久存档真实可查）采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【我们承诺采用的是学校原版纸张（纸质、底色、纹路），我们拥有全套进口原装设备，特殊工艺都是采用不同机器制作，仿真度基本可以达到98%以上，所有工艺效果都可提前给客户展示，不满意可以根据客户要求进行调整，直到满意为止！】
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信41543339】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信41543339】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
留信网服务项目：
1、留学生专业人才库服务（留信分析）
2、国（境）学习人员提供就业推荐信服务
3、留学人员区块链存储服务
→ 【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：客户在留信官方认证查询网站查询到认证通过结果后付款，不成功不收费！
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
The ginsenosides in Red Korean Ginseng work by stimulating the central nervous system, boosting energy levels, and improving physical performance.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Trauma Outpatient Center .
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
Alka magic plan 1350 -we deliver alkaline water at your door step and you can make handsome money by referral programme
we also help and provide systematic guideline to setup 1000 lph alkaline water plant
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure
ABDOMINAL COMPARTMENT SYSNDROME
CARE OF CLIENTS WITH LIFE-THREATENING CONDITIONS, ACUTELY ILL/ MULTI-ORGAN PROBLEMS, HIGH ACUITY AND EMERGENCY SITUATION
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
ULTRA HYPOFRACTIONATION
Accelerated Partial Breast Irradiation: :Brachytherapy
UK FAST FORWARD
Health Education on prevention of hypertension
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Top massage center in ajman chandrima Spa
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
CCSN_June_06 2024_jones. Cancer Rehabpptx
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Letter to MREC - application to conduct study
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Recently uploaded (20)
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Ginseng for Stamina Boost Your Energy and Endurance Naturally.pptx
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
All About Oncology --- Plunes HealthCare
- 2. 1 3 2 4 Key Aspects of Oncology Include: 1. Prevention: Oncologists work on identifying and minimizing risk factors associated with cancer. This can involve lifestyle changes, vaccinations (such as the HPV vaccine to prevent cervical cancer), and genetic counselling for individuals with a family history of certain cancers.
- 3. 2. Diagnosis: Early and accurate diagnosis is crucial for effective cancer treatment. Oncologists use various diagnostic tools, including imaging studies (such as CT scans and MRI), biopsies, and laboratory tests to identify cancer type, stage, and extent.
- 4. 3. Treatment: Oncology encompasses a range of treatment modalities, including surgery, chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted therapy, and stem cell transplant. The choice of treatment depends on the type and stage of cancer, as well as the patient's overall health.
- 5. 4. Research: Ongoing research in oncology aims to discover new treatments, improve existing ones, and better understand the underlying causes of cancer. Clinical trials are crucial in testing new therapies and advancing the field.
- 6. 5. Supportive Care: Oncology also involves providing supportive care to cancer patients, addressing symptoms, managing the side effects of treatments, and improving the overall quality of life during and after cancer treatment.
- 7. 6. Palliative Care: In cases where a cure is not possible, palliative care focuses on relieving symptoms, managing pain, and improving the comfort and well-being of patients.
- 8. Oncologists may specialize in specific types of cancer, such as breast, lung, or leukaemia, and work closely with other healthcare professionals to develop comprehensive and personalized treatment plans for each patient. The field of oncology is dynamic, with ongoing advancements in research and technology continually shaping how cancer is understood and treated.
- 9. Thank You!